Literature DB >> 2651729

Understanding investigative clinical trials.

R W Barnes1.   

Abstract

This article reviews the background, rationale, and principles of clinical trials and their role and influence on medical practice. The relationship of clinical trials to other forms of clinical studies is explored. The fundamentals of sound design, analysis, interpretation, and reporting of clinical trials are detailed. Ethical issues, costs, and limitations of trials are explored. The article reviews the trends in program content of 749 abstracts presented at the joint vascular surgical meetings during the past 17 years, demonstrating a significant increase in reported clinical trials during the last half of this period. Finally, future trends in the use of clinical trials to "validate" medical practice are suggested in response to efforts to control rising health care costs. Physicians, including vascular surgeons, must become knowledgeable in the principles of clinical trials to interpret more effectively, apply, or even participate in such clinical research.

Mesh:

Year:  1989        PMID: 2651729     DOI: 10.1016/0741-5214(89)90481-3

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  3 in total

1.  Serial noninvasive studies do not herald postoperative failure of femoropopliteal or femorotibial bypass grafts.

Authors:  R W Barnes; B W Thompson; C M MacDonald; M L Nix; A Lambeth; A D Nix; D W Johnson; B H Wallace
Journal:  Ann Surg       Date:  1989-10       Impact factor: 12.969

2.  Brain tumor protocols in North America.

Authors:  M Bernstein; J Rutka
Journal:  J Neurooncol       Date:  1993-09       Impact factor: 4.130

3.  Evaluation of clinical trials for natural products used in diabetes: An evidence-based systemic literature review.

Authors:  Rizwan Ahmad; Lina Hussain AlLehaibi; Hind Nasser AlSuwaidan; Ali Fuad Alghiryafi; Lyla Shafiq Almubarak; Khawlah Nezar AlKhalifah; Hawra Jassim AlMubarak; Majed Ali Alkhathami
Journal:  Medicine (Baltimore)       Date:  2021-04-23       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.